insitro is an exciting startup company that aims to take a new approach to drug development: one with big data and machine learning at its core.
B2C
51 to 100
Series B
$243M
Growth
2018
N/A
N/A
N/A
Yes
Active
Machine Learning
Natural Language Processing
Knowledge Representation and Reasoning
N/A
Software
11
1
$400M
Company was founded 2018 and it took almost 3 years (Mar 2021) to raise first external round
Interested in researching Insitro?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Insitro
Interested in what they do or partnership?
Learn more about how they work